Master of Antimalarial Resistance
National Immunization Advocate to Be Honored
Scientists Discover Potential New Way To Control Drug-resistant Bacteria
USF Microbiologists Can Detect Smallpox and Anthrax ASAP
Healthpoint Launches Accuzyme Spray, a New Pump Method of Delivery for Wound-Debridement Product
West Nile Virus Detected in Oregon Donors Blood
Washington, D.C. Department of Health Recognizes National Adult Immunization Awareness Week, Sept. 26 through Oct. 2, 2004
Mass Vaccination Exercise Planned for Colorado in October
New Indiana State Food Handler Requirement to Start in January
Minnesota Health Officials Investigate Rabies Cases
American Latex Allergy Association and Kimberly-Clark to Promote Awareness During Latex Allergy Week
Oral Amoxicillin Could be Future Treatment for Children with Pneumonia
In Natural Disasters, Cadavers Pose No Threat of Disease
IPM Enters Into a Preliminary Agreement With GlaxoSmithKline to Explore Potential of Anti-HIV Compounds as Microbicides
Newest Recommendations Highlight the Urgency for Childhood Influenza Vaccination
ASHES Announces Phoenix Award Winner
AHRMM Announces 2005 Election Results
NIOSH Publishes Alert on Preventing Occupational Exposure to Hazardous Drugs
Fall is the Time to Think About Flu Vaccinations for Kids
Flu Shot Locator on American Lung Association's lungusa.org Aims to Reduce Infections, Deaths
Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease
HHS Orders Avian Flu Vaccine Doses As Preventive Measure
World's Leading Infectious Disease Specialists Convene to Discuss the Prevention and Treatment of Global Health Threats
Scientists Decipher Genetic Code of Biothreat Pathogen
HIV Dementia Mechanism Discovered; Finding May Lead To New Therapies
Cancer Vaccines 2004: A Report From the World
Cannibis May Help Combat Cancer-causing Herpes Viruses
Revised Drinking Water Guidelines to Help Prevent Disease Outbreaks
FDA Grants Inhibitex Fast Track Designation for Aurexis
Coley Pharmaceutical Group Announces $16.9 Million Research Contract From NIH for Development of New Vaccine Adjuvants for Biodefense
